Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgens and cardiovascular disease.

Peter Y Liu1, Alison K Death, David J Handelsman

  • 1ANZAC Research Institute, Concord Hospital and Department of Medicine, University of Sydney, New South Wales, Australia.

Endocrine Reviews
|June 6, 2003
PubMed
Summary

Androgens, not estrogen, may explain earlier cardiovascular disease in men. Testosterone therapy shows potential for treating cardiac ischemia, but further research is needed for other conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of testosterone, sex hormone-binding globulin, and related hormones with risks of cancer death, incident cancer, and incident prostate cancer in men: individual participant data meta-analyses.

The lancet. Healthy longevity·2026
Same author

Associations between testosterone and pre-androgens and sexual function; findings from the Australian Women's Midlife Years Study.

Fertility and sterility·2026
Same author

Serum Androgen Profile of Elite Athletes.

The Journal of clinical endocrinology and metabolism·2026
Same author

The ontogeny of sex differences in exercise performance.

Journal of the Endocrine Society·2026
Same author

Protective effects of the FOXO3 gene in cardiometabolic disease in the Concord Health and Ageing in Men Project cohort.

The journals of gerontology. Series A, Biological sciences and medical sciences·2026
Same author

SRY gene screening in elite Athletics: rationale, science and implementation of the World Athletics Regulations.

British journal of sports medicine·2026

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Androgen Biology

Background:

  • Cardiovascular disease (CVD) is a leading cause of death globally, with men experiencing earlier onset than women.
  • The traditional estrogen protection hypothesis for premenopausal women is increasingly questioned.
  • Androgens, particularly testosterone, are being re-evaluated for their role in CVD progression.

Purpose of the Study:

  • To explore the role of androgens in the gender gap of cardiovascular disease.
  • To investigate potential therapeutic targets related to androgen action in CVD.
  • To assess the efficacy of testosterone therapy in various cardiovascular conditions.

Main Methods:

  • Review of existing literature on androgens, estrogen, and cardiovascular health.
  • Analysis of gender differences in age-specific cardiovascular death rates.
  • Evaluation of observational and interventional studies on testosterone therapy.

Main Results:

  • Androgen exposure, potentially from early life, may predispose males to earlier atherosclerosis.
  • Testosterone levels are lower in men with CVD, suggesting a potential protective role.
  • Testosterone therapy shows modest benefits in cardiac ischemia but not peripheral arterial disease.

Conclusions:

  • Androgens, rather than estrogen, are likely key to understanding the male-female lifespan gap in CVD.
  • Further research into androgen receptor pathways and metabolism is crucial for novel therapeutic strategies.
  • Testosterone therapy warrants further investigation for specific CVD applications, particularly cardiac ischemia.

Related Experiment Videos